ANTI-COAGULATION SELF-MONITORING ALLIANCE

That this House welcomes the Anti-Coagulation Self-Monitoring Alliance campaign to give greater choice and control to the estimated 1.25 million patients in the UK who take long-term warfarin; notes that only two per cent of these patients currently self-monitor their blood clotting time, despite evidence that self-monitoring is effective in improving health outcomes, convenient and saves money for the NHS; further welcomes the Government's efforts to mainstream assistive technology across the NHS; notes that innovative self-monitoring technologies support the important concepts of patient choice, empowerment, self-management and shared decision-making in the NHS; and calls on the Government to consider making self-monitoring devices available on NHS prescription to long-term warfarin patients in the UK.